Top News

Press Release | June 7, 2017
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker on today’s mark-up in the House Energy and Commerce Committee of the FDA Reauthorization Act of 2017:
Press Release | May 19, 2017
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker following introduction in the U.S. Senate of legislation (S. 1183) to streamline FDA’s medical technology review process:
Press Release | May 18, 2017
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker following introduction of legislation (H.R. 2474) in the U.S. House of Representatives that would create an alternative review approach for low- to moderate-risk medical devices and diagnostics:

Events

June
27
June 27, 2017 to June 28, 2017
| Washington, DC
During this workshop, you will be provided with the road-map and practical applications to successfully navigate the many potential reimbursement pitfalls. After an overview of current reimbursement... Read More
June
28
June 28, 2017 to June 29, 2017
| Washington, DC
This next level reimbursement workshop was created with the more advanced professional in mind. You'll walk away from this workshop with more insight into the complex and critical nature of coverage... Read More

Industry News

RealClear Health
Often undiagnosed, an estimated two to six million people in the United States have a serious heart condition called atrial fibrillation, or AFib. As those living with the disease know, complications from the irregular heartbeat caused by the AFib can be potentially devastating: The average person with AFib is five times more likely to suffer a stroke than someone with a regular heartbeat. Fortunately, there is innovative medical technology available today poised to make a real difference in...
Legal Backgrounder
When a doctor implants a medical device, he or she often requests the presence of a representative of the device manufacturer (a “rep”) in the operating room. Some observers are critical of this practice, demanding thatreps be barred from the O.R. At the same time,some lawyersthink repsin the O.R.should be subject to liability in the court system. This Legal Backgrounder explains why reps often play an important, if limited, role in the O.R., and why that role should not expose reps to lawsuits
Business Wire
ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes. The round was led by Philips and UPMC, through its innovation and commercialization arm UPMC Enterprises, with other new and existing investors participating. The funding will support a planned US-based pivotal trial for...
Washington Examiner
Imagine for a moment that you are one of the approximately 44 million women in the U.S. affected by cardiovascular disease, or one of the 24 million with osteoarthritis. You'd want access to the most advanced and effective care. Oftentimes, your doctor would recommend a medical technology or device as an essential component of your treatment – placing a stent in a blocked artery or replacing your knee or hip with a new artificial one, for example. ​​​​​​
Fox Business
Mar. 09, 2017 - AdvaMed CEO Scott Whitaker discusses the impact of the medical device tax on business.​​​​​​